Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study

doi:10.3748/wjg.v21.i9.2786

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9584)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

577

WORD

283

HTML

5292

Figures (1-2)

234

Tables (1-3)

216

Sum=6602

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1034

Download

1948

Sum=2982

Mar 7, 2015 (publication date) through Jan 22, 2025

Times Cited of This Article

Times Cited (99)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Mar 7, 2015; 21(9): 2786-2792
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2786

Table 1 Characteristics of the patients with Helicobacter pylori positive culture

Characteristic	2009-2010(n = 371)	2013-2014(n = 950)	P value
Gender (male/female), n	185/186	485/465	0.698
Age (yr), mean ± SD	41.9 ± 13.4	42.9 ± 13.2	0.215
Endoscopic findings, n
Peptic ulcer	60	184	0.320
Gastric erosions	75	200
No macroscopic abnormality	236	566
Histological findings, n
Non-atrophic gastritis	245	664	0.174
Atrophic gastritis	126	286	0.174

Table 2 Multiple resistance patterns in the Helicobacter pylori isolates n (%)

Multiple resistance pattern	2009-2010(n = 371)	2013-2014(n = 950)
Double resistance
CLA + MTZ	36 (9.7)	79 (8.3)
MTZ + LEV	29 (7.8)	94 (9.9)
MTZ + RIF	15 (4.0)	14 (1.5)
CLA + LEV	13 (3.5)	40 (4.2)
AMX + MTZ	3 (0.8)	3 (0.3)
MTZ + TET	3 (0.8)	2 (0.2)
CLA + RIF	2 (0.5)	11 (1.2)
AMX + CLA	2 (0.5)	4 (0.4)
CLA + TET	1 (0.3)	5 (0.5)
AMX + RIF	1 (0.3)	2 (0.2)
LEV + RIF	0	8 (0.8)
LEV + TET	0	5 (0.5)
AMX + LEV	0	1 (0.1)
Triple resistance
CLA + MTZ + LEV	34 (9.2)	171 (18.0)
CLA + MTZ + RIF	7 (1.9)	16 (1.7)
AMX + CLA + MTZ	6 (1.6)	4 (0.4)
MTZ + LEV + RIF	4 (1.1)	18 (1.9)
CLA + MTZ + TET	4 (1.1)	1 (0.1)
CLA + LEV + RIF	2 (0.5)	11 (1.2)
AMX + MTZ + LEV	2 (0.5)	2 (0.2)
AMX + MTZ + RIF	1 (0.3)	0
AMX + CLA + LEV	1 (0.3)	0
CLA + LEV + TET	1 (0.3)	3 (0.3)
MTZ + LEV + TET	0	10 (1.1)
AMX + CLA + RIF	0	1 (0.1)
CLA + TET + RIF	0	1 (0.1)
MTZ + TET + RIF	0	1 (0.1)
Quadruple resistance
CLA + MTZ + LEV + RIF	12 (3.2)	38 (4.0)
AMX + CLA + MTZ + LEV	4 (1.1)	9 (0.9)
CLA + MTZ + LEV + TET	4 (1.1)	8 (0.8)
MTZ + LEV + TET + RIF	1 (0.3)	8 (0.8)
AMX + MTZ + LEV + TET	1 (0.3)	0
AMX + MTZ + LEV + RIF	1 (0.3)	0
AMX + CLA + MTZ + RIF	0	3 (0.3)
CLA + MTZ + TET + RIF	0	2 (0.2)
CLA + LEV + TET + RIF	0	1 (0.1)
Quintuple resistance
CLA + MTZ + LEV + TET + RIF	1 (0.3)	17 (1.8)
AMX + CLA + MTZ + LEV + RIF	0	3 (0.3)
AMX + CLA + MTZ + LEV + TET	0	2 (0.2)
Sextuple resistance	1 (0.3)	1 (0.1)

AMX: Amoxicillin; CLA: Clarithromycin; LEV: Levofloxacin; MTZ: Metronidazole; RIF: Rifampicin; TET: Tetracycline.

Table 3 Influencing factors of antibiotic resistance of Helicobacter pylori isolates

Resistance rate (%)	GenderMale (n = 670),female (n = 651)	Age (yr)18-35 (n = 496),36-50 (n = 378),51-75 (n = 447)	Endoscopic findingsPUD (n = 244),NUD (n = 1077)
Amoxicillin	5.1, 5.1	4.2, 5.3, 5.8	2.9, 5.6
Clarithromycin	46.6, 51.6	50.8, 48.7, 47.4	36.5, 51.9^a (OR = 1.822; 95%CI: 1.364-2.433)
Metronidazole	59.4, 69.4^a (OR =1.504; 95%CI: 1.195-1.891)	63.3, 62.2, 67.3	58.6, 65.6
Levofloxacin	43.6, 54.8^a (OR =1.518; 95%CI: 1.219-1.891)	42.9, 53.4, 52.3^a (OR =1.199; 95%CI: 1.053-1.365)	45.1, 50.0
Tetracycline	7.2, 6.0	6.7, 4.5, 8.3	6.1, 6.7
Rifampicin	19.0, 15.8	16.7, 16.9, 18.6	20.9, 16.6

^aP < 0.05, the significant difference in levofloxacin resistence rate was observed among different age groups. PUD: Peptic ulcer disease; NUD: Non-ulcer disease; OR: Odds ratio; CI: Confidence interval.

Citation: Zhang YX, Zhou LY, Song ZQ, Zhang JZ, He LH, Ding Y. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study. World J Gastroenterol 2015; 21(9): 2786-2792
URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2786.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i9.2786